Safety and Immunogenicity of EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly in Semi-Immune Adults: A Phase 1, Double-Blinded Placebo Controlled Dosage Escalation StudyKwadwo Koram, Francis Nkrumah, Josephine Ocran et al.|PLoS ONE|2016Cited by 26